Valuation: 10x Genomics, Inc.

Market Cap 8.51B 7.58B 6.95B 6.32B 11.88B 804B 12.15B 83.09B 33.31B 425B 31.93B 31.25B 1,348B P/E 2026 *
-89.3x
P/E 2027 * -92.7x
Enterprise Value 8.06B 7.18B 6.59B 5.99B 11.26B 762B 11.51B 78.74B 31.57B 403B 30.26B 29.61B 1,277B EV / Sales 2026 *
13x
EV / Sales 2027 * 11.7x
Free-Float
90.93%
Yield 2026 *
-
Yield 2027 * -
1 day+3.44%
1 week-19.94%
Current month-4.51%
1 month-31.50%
3 months+39.89%
6 months+209.24%
Current year+310.48%
1 week 61.24
Extreme 61.24
84.4
1 month 61.24
Extreme 61.24
102.81
Current year 15.9
Extreme 15.9
102.81
1 year 12.8
Extreme 12.8
102.81
3 years 6.78
Extreme 6.78
102.81
5 years 6.78
Extreme 6.78
181.3
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 02/07/2012
President 51 01/10/2012
Director of Finance/CFO 51 12/08/2024
Director TitleAgeSince
Director/Board Member 51 02/07/2012
Director/Board Member 49 02/07/2012
Chairman 68 01/08/2013
Date Insider Type Main position Quantity % Market Cap. Importance
22/09/26 Sell

Director

-5,723 0.0048%
22/09/26 Sell

Founder

-25,000 0.0208%
09/09/26 Sell

Chief Financial Officer

-46,388 0.0386%
Change 5-day change 1-year change 3-year change Capi.($)
+3.45%-19.94%+401.12%+73.22% 8.51B
+5.81%+13.07%-7.75%+22.16% 189B
+6.33%+11.41%+16.78%+43.82% 121B
+9.75%+12.60%-5.60%+23.65% 118B
+2.63%+4.02%-40.35%+8.53% 94.78B
+4.28%+8.86%+2.49%+79.35% 64.98B
+5.20%+7.30%+16.96%-19.18% 53.98B
+3.83%+25.04%-2.53%+66.39% 52.94B
-1.45%-7.41%-2.67%+59.52% 52.3B
+5.75%+9.90%+7.33%-5.58% 35.25B
Average +4.50%+2.20%+38.58%+35.19% 79.13B
Weighted average by Cap. +5.23%+4.17%+0.70%+30.68%

Financials

2026 *2027 *
Net sales 621M 553M 507M 461M 866M 58.65B 886M 6.06B 2.43B 31.04B 2.33B 2.28B 98.33B 683M 609M 558M 507M 954M 64.58B 976M 6.67B 2.68B 34.18B 2.56B 2.51B 108B
Net income -95.86M -85.42M -78.34M -71.19M -134M -9.06B -137M -936M -375M -4.79B -360M -352M -15.19B -90.23M -80.4M -73.73M -67.01M -126M -8.53B -129M -881M -353M -4.51B -339M -331M -14.3B
Net Debt -445M -396M -363M -330M -621M -42.01B -635M -4.34B -1.74B -22.24B -1.67B -1.63B -70.44B -527M -469M -430M -391M -735M -49.78B -752M -5.14B -2.06B -26.35B -1.98B -1.93B -83.46B
Projected Income Statement - Annual - 10x Genomics, Inc.
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems. Its products are used across diverse fields, from cancer research and immunology to neuroscience and developmental biology. Its commercial product portfolio is made up of its Single Cell and Spatial solutions. Its products include its instruments, which include its Chromium instruments, its Visium CytAssist and its Xenium Analyzer, and its consumables, which include proprietary microfluidic chips, slides, reagents and other consumables for its Single Cell and Spatial solutions. It bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. It also provides post-warranty service contracts for its instruments.
Employees
1,178
Date Price Change Volume
05/11/26 $67.52 +3.42% 2,923,059
03/11/26 $65.29 +5.94% 2,631,265
02/11/26 $61.63 -12.10% 5,174,089
30/10/26 $70.11 -14.03% 5,218,776
29/10/26 $81.55 -2.48% 1,860,047
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
MarketScreener Ratings - 10x Genomics, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
65.29USD
Average target price
77.50USD
Spread / Average Target
+18.70%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - 10x Genomics, Inc.